-Down to Earth Giving Patents to foreign-made medicines will add to patients' woes, they urge Health activists staged a protest in front of the office of Union Ministry of Health and Family Welfare on Friday, demanding that the government should ensure that oral drugs to treat Hepatitis C are made available to patients. The demonstrators were later assured by the ministry officials that they would look into the matter...
More »SEARCH RESULT
Total Matching Records found : 243
What lies beneath-Harshini Vakkalanka
-The Hindu Environmental activist Vandana Shiva says the real motives behind GMOs are the Patents and royalties that come with it Two things happened in 1984, begins environmental activist Vandana Shiva. One was Operation Blue star and the second, the riots following the assassination of the Prime Minister Indira Gandhi. "Something happened before Operation Blue Star and that story doesn't get told, that is the story of the Green Revolution," said Shiva,...
More »India must call the US' bluff on Patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »Smuggled Medicines Save Lives -Ashfaq Yusufzai
-IPS News PESHAWAR, Pakistan- They are contraband, yet a large number of Pakistanis have come to depend on drugs made in India and smuggled into Pakistan. Patients as well as doctors say these are cheap and effective, even as law enforcers look the other way. The two countries do not have a trade agreement on drugs, but markets in Khyber Pakhtunkhwa province in the north of Pakistan do brisk business in India-made...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »
